Both in Pharmaceuticals
Vertex Pharmaceuticals vs Abbott Laboratories
Over the past year VRTX returned +31.2% and ABT returned −14.2%; their daily moves had a correlation of 0.20.
VRTX +31.2% ABT −14.2%Growth of $1, one year, split-adjusted
| Metric | VRTX | ABT |
|---|---|---|
| Price | $558.88 | $106.20 |
| Market cap | $141.65B | $183.77B |
| Today | +3.50% | +1.56% |
| 1 month | +10.3% | +9.8% |
| 6 months | +31.8% | +18.7% |
| Year to date | +23.3% | −15.2% |
| 1 year | +34.0% | −14.7% |
| Revenue growth (YoY) | +12.5% | +13.0% |
| Gross margin | 85.3% | 57.7% |
| Net margin | 33.0% | 7.4% |
| P/E (TTM) | 32.2× | 33.9× |
| Price / sales | 11.3× | 3.9× |
| Net cash | $7.85B | -$27.00B |
| Dividend yield | — | 2.37% |
| Volatility (60d) | 28.7% | 21.3% |
| Short % of float | 1.7% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).